Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension
Arq Bras Cardiol. 2022 Sep;119(3):502-504.
doi: 10.36660/abc.20210931.
[Article in
English,
Portuguese]
Authors
Jannis Kountouras
1
, Apostolis Papaefthymiou
1
2
3
, Stergios A Polyzos
3
, Evangelos Kazakos
1
, Elisabeth Vardaka
1
4
, Maria Touloumtzi
1
, Maria Tzitiridou-Chatzopoulou
1
5
, Christos Liatsos
6
, Ioanna-Konstantina Sgantzou
7
, Jürg Knuchel
8
, Michael Doulberis
1
3
8
Affiliations
- 1 Second Medical Clinic, School of Medicine, Ippokration Hospital, Aristotle University of Thessaloniki, Macedônia - Grécia.
- 2 Department of Gastroenterology, University Hospital of Larisa, Larisa - Grécia.
- 3 First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Macedônia - Grécia.
- 4 Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, Macedônia - Grécia.
- 5 School of Healthcare Sciences, Midwifery Department, University of West Macedonia, Macedônia - Grécia.
- 6 Department of Gastroenterology - General Military Hospital of Athens, Atenas - Grécia.
- 7 Radiology Department, University Hospital of Larisa, Larisa - Grécia.
- 8 Division of Gastroenterology and Hepatology, Medical University Department, Aarau - Suíça.
No abstract available
MeSH terms
-
Helicobacter Infections* / complications
-
Helicobacter Infections* / metabolism
-
Helicobacter pylori*
-
Humans
-
Hypertension* / complications
-
Metabolic Syndrome* / complications
-
Prevalence